Home > Healthcare > Pharmaceuticals > Finished Drug Form > Heparin Market
Heparin Market size was worth over USD 4.8 billion in 2022. Driven by the high prevalence rate of chronic disorders globally, the industry could grow at over 2.5% CAGR from 2023 to 2032.
Surging occurrence of chronic disorders such as coronary artery disease, thromboembolism, and others that result in blood clot formation has increased the need for heparin. As per CDC, in 2021, 2 in every 10 mortalities from coronary artery disease occurred in adults below the age of 65 years. Moreover, the growing demand for anticoagulants in hemodialysis, open heart surgery, and other interventional procedures will create ample opportunities for industry expansion.
Report Attribute | Details |
---|---|
Base Year: | 2022 |
Heparin Market Size in 2022: | USD 4,841.5 Million |
Forecast Period: | 2023 to 2032 |
Forecast Period 2023 to 2032 CAGR: | 2.6% |
2032 Value Projection: | USD 6,405.0 Million |
Historical Data for: | 2018 to 2022 |
No. of Pages: | 160 |
Tables, Charts & Figures: | 287 |
Segments covered: | Product, Source, Application, Distribution Channel, Region |
Growth Drivers: |
|
Pitfalls & Challenges: |
|